Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Cash Flows From Operating Activities:
Net loss	$ (3,101,768)	$ (3,554,683)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation	2,850	3,025
Non-cash lease expense	45,097	52,883
Depreciation	8,921	10,895
Changes in operating assets and liabilities
Short term receivables	(82)	4,481
Prepaid expenses and other current assets	451,425	122,914
Accounts payable	(418,370)	807,073
Unearned grant revenue	(557,710)	(989,042)
Other accrued expenses	836,426	402,390
Operating lease liability	(44,422)	(58,262)
Accrued interest	205,655	156,854
Net Cash Used In Operating Activities	(2,571,978)	(3,041,472)
Cash Flows From Financing Activities:
Proceeds from issuance of convertible notes payable	800,000	625,000
Proceeds from issuance of convertible notes payable - related parties	1,675,000	1,002,500
Repayment of short-term note payable	(283,445)	(259,659)
Net Cash Provided By Financing Activities	2,191,555	1,367,841
Effect of exchange rates on cash and restricted cash	(24,485)	(1,604)
Net Decrease In Cash and Restricted Cash	(404,908)	(1,675,235)
Cash and Restricted Cash, Beginning of Period	1,431,707	3,106,942
Cash and Restricted Cash, End of Period	1,026,799	1,431,707
Cash	76,576	21,605
Restricted cash	950,223	1,410,102
Supplemental Disclosures of Cash Flow Information:
Interest
Income taxes
Non-cash investing and financing activities:
Deposit applied to equity issuances		(150,000)
Right-of-use assets obtained in exchange for operating lease liabilities		130,443
Conversion of 2021 Notes and related accrued interest to Series D-1 Preferred Stock	945,467	1,361,640
Conversion of 2022 Notes and related accrued interest to Series D-1 Preferred Stock	813,098
Purchase of insurance policies financed by short-term note payable	$ (306,050)	$ (203,175)